Literature DB >> 15465919

Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells.

Min Dong1, William H Tepp, Eric A Johnson, Edwin R Chapman.   

Abstract

Botulinum neurotoxins (BoNTs) act as zinc-dependent endopeptidases that cleave proteins required for neurotransmitter release. To detect toxin activity, fragments of the toxin substrate proteins, synaptobrevin (Syb) or synaptosome-associated protein of 25 kDa (SNAP-25), were used to link cyan fluorescent protein (CFP) to yellow fluorescent protein (YFP). Cleavage of these fusion proteins by BoNTs abolished fluorescence resonance energy transfer between the CFP and YFP, providing a sensitive means to detect toxin activity in real-time in vitro. Furthermore, using full-length SNAP-25 and Syb as the linkers, we report two fluorescent biosensors that can detect toxin activity within living cells. Cleavage of the SNAP-25 fusion protein abolished fluorescence resonance energy transfer between CFP and YFP, and cleavage of Syb resulted in spatial redistribution of YFP fluorescence in cells. This approach provides a means to carry out cell-based screening of toxin inhibitors and to study toxin activity in situ. By using these biosensors, we found that the subcellular localizations of SNAP-25 and Syb are critical for efficient cleavage by BoNT/A and B, respectively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15465919      PMCID: PMC522023          DOI: 10.1073/pnas.0404107101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  SNAP-25 is targeted to the plasma membrane through a novel membrane-binding domain.

Authors:  S Gonzalo; W K Greentree; M E Linder
Journal:  J Biol Chem       Date:  1999-07-23       Impact factor: 5.157

2.  DsRed as a potential FRET partner with CFP and GFP.

Authors:  Michael G Erickson; Daniel L Moon; David T Yue
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

3.  Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin.

Authors:  S Yamasaki; A Baumeister; T Binz; J Blasi; E Link; F Cornille; B Roques; E M Fykse; T C Südhof; R Jahn
Journal:  J Biol Chem       Date:  1994-04-29       Impact factor: 5.157

4.  VAMP/synaptobrevin cleavage by tetanus and botulinum neurotoxins is strongly enhanced by acidic liposomes.

Authors:  Paola Caccin; Ornella Rossetto; Michela Rigoni; Eric Johnson; Giampietro Schiavo; Cesare Montecucco
Journal:  FEBS Lett       Date:  2003-05-08       Impact factor: 4.124

5.  Proteolytic cleavage of synthetic fragments of vesicle-associated membrane protein, isoform-2 by botulinum type B neurotoxin.

Authors:  C C Shone; C P Quinn; R Wait; B Hallis; S G Fooks; P Hambleton
Journal:  Eur J Biochem       Date:  1993-11-01

6.  Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy.

Authors:  Tatiana Sorkina; Suzanne Doolen; Emilia Galperin; Nancy R Zahniser; Alexander Sorkin
Journal:  J Biol Chem       Date:  2003-05-13       Impact factor: 5.157

7.  Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat synaptobrevin 2.

Authors:  S Yamasaki; T Binz; T Hayashi; E Szabo; N Yamasaki; M Eklund; R Jahn; H Niemann
Journal:  Biochem Biophys Res Commun       Date:  1994-04-29       Impact factor: 3.575

8.  Plasma membrane localization signals in the light chain of botulinum neurotoxin.

Authors:  Ester Fernández-Salas; Lance E Steward; Helen Ho; Patton E Garay; Sarah W Sun; Marcella A Gilmore; Joseph V Ordas; Joanne Wang; Joseph Francis; K Roger Aoki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

9.  Plasma membrane targeting of SNAP-25 increases its local concentration and is necessary for SNARE complex formation and regulated exocytosis.

Authors:  Darshan K Koticha; Ellen E McCarthy; Giulia Baldini
Journal:  J Cell Sci       Date:  2002-08-15       Impact factor: 5.285

10.  Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells.

Authors:  Min Dong; David A Richards; Michael C Goodnough; William H Tepp; Eric A Johnson; Edwin R Chapman
Journal:  J Cell Biol       Date:  2003-09-22       Impact factor: 10.539

View more
  39 in total

1.  Synaptic vesicle chips to assay botulinum neurotoxins.

Authors:  Géraldine Ferracci; Raymond Miquelis; Shunji Kozaki; Michael Seagar; Christian Lévêque
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

2.  A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies.

Authors:  Sabine Pellett; William H Tepp; Colin M Clancy; Gary E Borodic; Eric A Johnson
Journal:  FEBS Lett       Date:  2007-09-12       Impact factor: 4.124

3.  A fluorescence detection platform using spatial electroluminescent excitation for measuring botulinum neurotoxin A activity.

Authors:  Kim E Sapsford; Steven Sun; Jesse Francis; Shashi Sharma; Yordan Kostov; Avraham Rasooly
Journal:  Biosens Bioelectron       Date:  2008-06-18       Impact factor: 10.618

4.  Improved detection of botulinum neurotoxin serotype A by Endopep-MS through peptide substrate modification.

Authors:  Dongxia Wang; Jakub Baudys; Yiming Ye; Jon C Rees; John R Barr; James L Pirkle; Suzanne R Kalb
Journal:  Anal Biochem       Date:  2012-09-24       Impact factor: 3.365

5.  In vitro detection and quantification of botulinum neurotoxin type e activity in avian blood.

Authors:  Timothy M Piazza; David S Blehert; F Mark Dunning; Brenda M Berlowski-Zier; Füsûn N Zeytin; Michael D Samuel; Ward C Tucker
Journal:  Appl Environ Microbiol       Date:  2011-09-09       Impact factor: 4.792

Review 6.  Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discovery.

Authors:  Erkan Kiris; Krishna P Kota; James C Burnett; Veronica Soloveva; Christopher D Kane; Sina Bavari
Journal:  Expert Rev Mol Diagn       Date:  2014-01-23       Impact factor: 5.225

7.  A high content imaging assay for identification of Botulinum neurotoxin inhibitors.

Authors:  Krishna P Kota; Veronica Soloveva; Laura M Wanner; Glenn Gomba; Erkan Kiris; Rekha G Panchal; Christopher D Kane; Sina Bavari
Journal:  J Vis Exp       Date:  2014-11-14       Impact factor: 1.355

8.  Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo Assays.

Authors:  Paul T Bremer; Michael Adler; Cecilia H Phung; Ajay K Singh; Kim D Janda
Journal:  J Med Chem       Date:  2017-01-03       Impact factor: 7.446

9.  Lab-on-a-chip for botulinum neurotoxin a (BoNT-A) activity analysis.

Authors:  Steven Sun; Miguel Ossandon; Yordan Kostov; Avraham Rasooly
Journal:  Lab Chip       Date:  2009-09-17       Impact factor: 6.799

10.  Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents.

Authors:  Jerry O Conway; Laura J Sherwood; M Thelma Collazo; John A Garza; Andrew Hayhurst
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.